The market head in extravascular closure devices.

‘We experienced that it had been crucial to offer a solution for our customers who utilize the radial approach,’ stated Gregory D. Casciaro, President and CEO of AccessClosure.’ Related StoriesAdvances in thoracic surgery: an interview with Dan Wildman, VP Global Franchise Strategy & Technology – EthiconBMBF provides EUR 25 million to aid CTH's Integrated Research and CENTERS programFirst patient signed up for CryoLife's PerClot IDE clinical trialThe Bengal was designed in partnership with radial pioneer Olivier F.Copyright 2009 Advisory Board Firm and Kaiser Family Basis. All rights reserved.. Jessica S. Albert, Ph.D., Laura M. Yerges-Armstrong, Ph.D., Richard B. Horenstein, M.D., Toni I. Pollin, Ph.D., Urmila T. Sreenivasan, M.S., Sumbul Chai, M.S., William S. Blaner, Ph.D., Soren Snitker, M.D., Ph.D., Jeffrey R. O’Connell, Ph.D., Da-Wei Gong, Ph.D., Richard J. Breyer, III, M.D., Alice S. Ryan, Ph.D., John C. McLenithan, Ph.D., Alan R. Shuldiner, M.D., Carole Sztalryd, Ph.D., and Coleen M. Damcott, Ph.D.: Null Mutation in Hormone-Sensitive Lipase Risk and Gene of Type 2 Diabetes Both excess and insufficient storage of lipids in white adipose tissue are associated with dyslipidemia, insulin resistance, and an elevated risk of type 2 diabetes; thus, maintaining normal white-adipose-tissue function is crucial for whole-body insulin sensitivity and energy homeostasis.1 Hormone-sensitive lipase , encoded by LIPE, is an intracellular lipase with many neutral lipid substrates, including triglycerides, diglycerides, monoglycerides, cholesterol esters, and retinyl esters.